Evidence map›Paper›PMID 41882034›Full record

ArticleScientific reports2026

High-throughput adult Caenorhabditis elegans viability monitoring system.

Qizhao Lin, Jinfang Weng, Zhishuang Cheng, Jian Guo, Renhui Zhang, Jiachen Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qizhao LinFujian Polytechnic of Information Technology, Fuzhou, 350003, China.
Jinfang WengFujian Polytechnic of Information Technology, Fuzhou, 350003, China. 770840212@qq.com.
Zhishuang ChengFuzhou Hongniu Electronics Co., Ltd., Fuzhou, 363500, China.
Jian GuoFujian Polytechnic of Information Technology, Fuzhou, 350003, China.
Renhui ZhangFujian Shangyuan Biotechnology Co., Ltd., Fuzhou, 350004, China.
Jiachen ZhangSchool of Computer and Data Sciences, University of Oregon, Eugene, OR, 97403, USA. jiaz@uoregon.edu.

Funding

the Key Science Research & Cultivation Project of Fujian Polytechnic of Information Technology YZDKJ23-02
6 · The paper itself

Abstract

Caenorhabditis elegans (C. elegans) is a key model organism in human disease research. However, conventional automated monitoring systems face notable limitations including poor image quality from insufficient illumination and target misidentification caused by complex backgrounds, which severely impede reliable high-throughput experiments. To address these issues, we developed an integrated hardware-software high-throughput C. elegans lifespan monitoring system. At the hardware level, collimated illumination technology ensures uniform lighting for high-quality imaging, while a stepper motor-driven linear rail combined with industrial cameras enables stable and automated patrol imaging of large-scale Petri dishes. On the software side, the system optimizes target detection through iterative image processing, adopts a two-stage detection algorithm that reduces the miss rate from 1.75% to 0.8%, and integrates a dedicated viability assessment algorithm for accurate distinction between live and dead worms. Validated with adult C. elegans using manual counting as the gold standard, the system achieves over 95% live-count accuracy. It processes a single batch of 36 Petri dishes in 36–60 min, boosting throughput to 4–5 times that of manual operation. Long-term 30-day monitoring validation confirms extremely high consistency with manual results, with a Pearson correlation coefficient of 0.999 for live counts. This system is providing a robust tool for aging mechanism research and anti-aging drug screening.

Indexed as

Caenorhabditis elegansHigh-Throughput Screening AssaysAlgorithmsAnimalsImage Processing, Computer-AssistedLongevitySoftware

Identifiers

PMID41882034
PMCPMC13172445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.